{"id":"W2947759305","doi":"10.1200/jco.2019.37.15_suppl.9504","title":"United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Discontinuation; Ipilimumab; Adverse effect; Placebo; Adjuvant; Hazard ratio; Randomized controlled trial; Intention-to-treat analysis; Oncology; Gastroenterology; Surgery; Cancer; Confidence interval; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01302889,0.0003821558,0.006072917,0.0008625466,0.00006169707,0.00002383703,0.0006419047,0.000553945,0.007259981],"category_scores_gemma":[0.01728824,0.0002359594,0.001113654,0.0006014834,0.0005131989,0.0001582833,0.000252214,0.002136785,0.00004242736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004218579,"about_ca_system_score_gemma":0.001634815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006872066,"about_ca_topic_score_gemma":0.0006440645,"domain_scores_codex":[0.9885586,0.00365412,0.005734921,0.0005055959,0.0009453779,0.0006013691],"domain_scores_gemma":[0.959725,0.03274529,0.003908312,0.0007242169,0.002253945,0.0006432557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9213307,0.01409949,0.0007656218,0.00009108141,0.005422723,0.0004500967,0.001088257,0.00003989474,0.002846339,0.00002331105,0.003107153,0.05073534],"study_design_scores_gemma":[0.7199144,0.259517,0.0008889875,0.000189634,0.001652406,0.00006346353,0.002435251,0.002190805,0.0005329276,0.0001482385,0.01229057,0.00017627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909097,0.0001938481,0.0002401332,0.001349075,0.003342591,0.003660415,0.00004552241,0.00002831599,0.0002304124],"genre_scores_gemma":[0.9915907,0.001191566,0.00120753,0.0002831179,0.0009760213,0.0000713998,0.00007200609,0.00007702867,0.004530603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2454175,"threshold_uncertainty_score":0.9936475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1243248276908649,"score_gpt":0.4960098934329372,"score_spread":0.3716850657420723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}